A Double-blinded, Randomized Control Trial of Prophylactic Ondansetron in a Post-operative Cardiac Surgery Population for Post-operative Nausea and Vomiting
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Ondansetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 12 Mar 2018 Status changed from not yet recruiting to recruiting.
- 08 Dec 2017 Planned End Date changed from 1 May 2018 to 1 Apr 2018.
- 08 Dec 2017 Planned initiation date changed from 1 Feb 2018 to 1 Dec 2017.